Anne Valat Email

Director Research . Bolden Therapeutics

Current Roles

Employees:
9
Revenue:
$697.5k
About
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases such as Alzheimer’s and ischemic stroke. The company’s scientific founders have identified a key molecular pathway to stimulate neural stem cells to promote the birth of new neurons (neurogenesis) in the adult brain. In a proprietary mouse model Bolden has established a proof-of-concept of this approach to increase neurogenesis and enhance hippocampal-dependent memory. The company is actively developing antisense oligonucleotide and monoclonal antibody therapeutics to modulate this pathway.
Bolden Therapeutics Address
225 Dyer Street
Providence, RI
Bolden Therapeutics Email

Past Companies

Bolden TherapeuticsDirector of Research
Bolden TherapeuticsPrincipal Scientist
Bolden TherapeuticsResearch Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.